Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
T.PYR: Contract Toward Titanium Powder Supply & Distribution Agreement with Asian Materials Co. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Cerus Corp CERS

Healthcare Medical Devices
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also... see more

Recent & Breaking News (NDAQ:CERS)

Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

Business Wire March 16, 2026

Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

Business Wire March 2, 2026

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

Business Wire February 20, 2026

Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

Business Wire February 17, 2026

DRK Blood Donation Service Baden-Württemberg - Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT(TM) Blood System in Routine Clinical Practice

Business Wire January 22, 2026

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

Business Wire January 11, 2026

Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

Business Wire December 10, 2025

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Business Wire November 6, 2025

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

Business Wire October 21, 2025

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

Business Wire October 16, 2025

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Business Wire August 25, 2025

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Business Wire August 21, 2025

Cerus Corporation Announces Second Quarter 2025 Financial Results

Business Wire August 5, 2025

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Business Wire July 22, 2025

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Business Wire July 21, 2025

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Business Wire July 2, 2025

Cerus Corporation Celebrates World Blood Donor Day 2025

Business Wire June 13, 2025

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Business Wire June 3, 2025

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

Business Wire May 29, 2025

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 - Next-Generation INTERCEPT Illumination Device

Business Wire May 28, 2025

Podcasts